Extramedullary BCR-ABL1-negative myeloid leukemia in a patient with chronic myeloid leukemia and synchronous cytogenetic abnormalities in Philadelphia-positive and -negative clones during imatinib therapy

[1]  H. Kantarjian,et al.  Chromosomal Abnormalities in Philadelphia Chromosome (Ph)-Negative Metaphases Appearing during Novel Tyrosine Kinase Inhibitors (NTKI) Therapy in Patients (pts) with Chronic Myeloid Leukemia (CML) after Imatinib-Failure. , 2006 .

[2]  H. Kantarjian,et al.  Myelodysplastic syndromes and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemia. , 2006, Blood.

[3]  Jorge Cortes,et al.  Clonal evolution in chronic myelogenous leukemia. , 2004, Hematology/oncology clinics of North America.

[4]  M. Deininger,et al.  Clonal Cytogenetic Abnormalities in Philadelphia Chromosome Negative Cells in Chronic Myeloid Leukemia Patients Treated with Imatinib , 2004, Leukemia & lymphoma.

[5]  H. Kantarjian,et al.  Chromosomal abnormalities in Philadelphia chromosome‐negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome‐positive chronic myelogenous leukemia in chronic phase , 2003, Cancer.

[6]  C. Herold,et al.  Simultaneous occurrence of a t(9;22) (Ph) with a t(2;11) in a patient with CML and emergence of a new clone with the t(2;11) alone after imatinib mesylate treatment , 2003, Leukemia.

[7]  M. Talpaz,et al.  Emergence of new clonal abnormalities following interferon-alpha induced complete cytogenetic response in patients with chronic myeloid leukemia: report of three cases , 1997, Leukemia.

[8]  F. Pasquali,et al.  Trisomy 8 in philadelphia chromosome (ph1)‐negative cells in the course of ph1‐positive chronic myelocytic leukemia , 1992, Genes, chromosomes & cancer.

[9]  J. J. Buckley,et al.  Report of Three Cases , 1962 .